share_log

東曜藥業-B:有關 VIVO CAPITAL FUND VIII 向本公司一間附屬公司注資的 關連交易

TOT BIOPHARM-B: CONNECTED TRANSACTION IN RELATION TO CAPITAL INJECTION BY VIVO CAPITAL FUND VIII INTO A SUBSIDIARY OF THE COMPANY

Jan 7, 2022 09:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more